You have 9 free searches left this month | for more free features.

Condition

Multiple Myeloma (2)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

SecuraBio (1)

Collaborator

Intervention

farydak (2)

dexamethasone (1)

revlimid (1)

velcade (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

farydak

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Multiple Myeloma Trial in United States (Farydak)

Recruiting

Multiple Myeloma

Farydak

Indianapolis, Indiana
+6 more

Mar 15, 2021

Multiple Myeloma Trial in United States (Revlimid, Velcade, dexamethasone)

Terminated

Multiple Myeloma

Revlimid
+3 more

Los Angeles, California
+4 more

Jun 26, 2018